<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160809029281N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-16</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of castor oil and evening primrose on cervical  ripening</public_title>
      <acronym></acronym>
      <scientific_title>Comparision between the effects of castor oil and  evening primrose oil on cervical ripening  of Nuli Par women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>114</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59943</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: The samples will be selected by easy sampling method and then they will be randomly divided into three groups: intervention 1 (60 cc of castor oil), intervention 2 (1000 cc of evening primrose vaginal capsule) and group 3 (control). And then the random allocation of samples will be such that 114 envelopes will be prepared and named equally with code 1, 2, and 3. The codes will be inside the envelopes and will be closed in the envelopes. Those who choose envelopes with code 1 will be in intervention group 1, those who choose envelopes with code 2 will be in intervention group 2, and those who will choose envelopes with code 3 will be in the control group, Blinding description: Participants do not know how to intervene.</study_design>
      <phase>3</phase>
      <hc_freetext>cervix ripening.</hc_freetext>
      <i_freetext>Intervention 1: After taking a stress-free test, the researcher is given group A 60 cc of castor oil (produced by Dineh Aromatic Company). Avoid other traditional methods to start labor and danger signs are taught according to the national protocol. The researcher provides the follow-up form to the samples. The subjects in each group are rejected up to 48 hours after the intervention in such a way that every 6-8 hours during the telephone call, the onset of contractions is asked in case of contractions (length one). At least 8 hours of contractions) refer to the desired hospitals and if the contractions do not start within 48 hours after the intervention, the research units in all three groups refer to selected hospitals for hospitalization. Intervention 2: Group B is given 1000 mg vaginal evening primrose capsule (Amin Iran Pharmaceutical Company). The dose of drugs is determined according to the studies performed by the pharmaceutical specialists of Amin Pharmaceutical Company and Dineh Iran Industrial Complex. Traditional abstinence to begin childbirth and danger signs are taught according to national protocol. The researcher provides the follow-up form to the samples. The subjects in each group are rejected up to 48 hours after the intervention in such a way that every 6-8 hours during the telephone call, the onset of contractions is asked in case of contractions (length one). At least 8 hours of contractions) refer to the desired hospitals and if the contractions do not start within 48 hours after the intervention, the research units in all three groups refer to selected hospitals for hospitalization. Intervention 3: Control group:  group C does not involve any intervention other than routine treatment. Research units are instructed to avoid enema, laxatives, herbal or chemical drugs, or other traditional methods of initiating labor during this period, and danger signs are taught according to the national protocol. The researcher provides the follow-up form to the samples. The subjects in each group are rejected up to 48 hours after the intervention in such a way that every 6-8 hours during the telephone call, the onset of contractions is asked in case of contractions (length one). At least 8 hours of contractions) refer to the desired hospitals and if the contractions do not start within 48 hours after the intervention, the research units in all three groups refer to selected hospitals for hospitalization.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Not yet published</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fateme Moshirenia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Timsar Fallahi Ave.yazd Town</address>
        <city>yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8943163589</zip>
        <telephone>+98 35 3521 1698</telephone>
        <email>f.moshirenia@gmail.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fateme Moshirenia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Timsar Fallahi Ave.,yazd Town</address>
        <city>yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8943163589</zip>
        <telephone>+98 35 3521 1698</telephone>
        <email>f.moshirenia@gmail.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Iranian citizenship
Single twin
BiShop score below four4
Tend to have a normal delivery
a low-risk pregnancy (no diabetes, no preeclampsia, bleeding, etc.)
Age 18-35   years
Having h eight shorter than 150 cm
Water bag closed
Fetal weight according to sono2500-4000
No bleeding diseases
Head displayFetal health according to sono
Fetal health according to sono
No known or systemic chronic diseases in the mother</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Use of any narcotics or herbal medicines
Any vaginal bleeding
Having a midwife with a private</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>After taking a stress-free test, the researcher is given group A 60 cc of castor oil (produced by Dineh Aromatic Company). Avoid other traditional methods to start labor and danger signs are taught according to the national protocol. The researcher provides the follow-up form to the samples. The subjects in each group are rejected up to 48 hours after the intervention in such a way that every 6-8 hours during the telephone call, the onset of contractions is asked in case of contractions (length one). At least 8 hours of contractions) refer to the desired hospitals and if the contractions do not start within 48 hours after the intervention, the research units in all three groups refer to selected hospitals for hospitalization.</i_keyword>
      <i_keyword>Group B is given 1000 mg vaginal evening primrose capsule (Amin Iran Pharmaceutical Company). The dose of drugs is determined according to the studies performed by the pharmaceutical specialists of Amin Pharmaceutical Company and Dineh Iran Industrial Complex. Traditional abstinence to begin childbirth and danger signs are taught according to national protocol. The researcher provides the follow-up form to the samples. The subjects in each group are rejected up to 48 hours after the intervention in such a way that every 6-8 hours during the telephone call, the onset of contractions is asked in case of contractions (length one). At least 8 hours of contractions) refer to the desired hospitals and if the contractions do not start within 48 hours after the intervention, the research units in all three groups refer to selected hospitals for hospitalization.</i_keyword>
      <i_keyword>Control group:  group C does not involve any intervention other than routine treatment. Research units are instructed to avoid enema, laxatives, herbal or chemical drugs, or other traditional methods of initiating labor during this period, and danger signs are taught according to the national protocol. The researcher provides the follow-up form to the samples. The subjects in each group are rejected up to 48 hours after the intervention in such a way that every 6-8 hours during the telephone call, the onset of contractions is asked in case of contractions (length one). At least 8 hours of contractions) refer to the desired hospitals and if the contractions do not start within 48 hours after the intervention, the research units in all three groups refer to selected hospitals for hospitalization</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cervical ripening. Timepoint: 40 weeks of pregnancy, 48 hours after intervention. Method of measurement: Determine the B-score score, which includes five characteristics: dilatation, effusion, fetal position, consistency, and cervical condition. The most common scoring system is to predict the success or failure of induction of labor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-31</approval_date>
        <contact_name>Ethics Committee in Research Infertility Research Center - Shahid Sadoughi University of Medical Sci</contact_name>
        <contact_address>Timsar fallahi  Ave.,yazd Town yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
